Articles by Keyword for

  Patients with low risk prostate cancer under active surveillance may benefit from vitamin D3 supplementation at 4000 IU per day according to an article in the Journal of Endocrinology Metabolism. In patients with Gleason 6 prostate cancers, those treated with 4000 IU of vitamin D3 for one year, 55% had a decrease in Gleason findings or fewer positive...